IP Verse

Generics [uk] Ltd opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Generics [uk] Ltd

Patent Number:
EP3342411
Title:
Rapamycin Derivative For Treating Pancreas Cancer
Applicant:
NOVARTIS AG
Opposition Date:
May 5, 2020
Patent Number:
EP3150610
Title:
Salts And Polymorphs Of 8-Fluoro-2-{4-[(Methylamino}Methyl]Phenyl}-1,3,4,5-Tetrahydro-6H-Azepino[5,4,3-Cd]Indol-6-One
Applicant:
PFIZER INC.
Opposition Date:
Apr 30, 2020
Patent Number:
EP2451445
Title:
Process For Drying Of Bibw2992, Of Its Salts And Of Solid Pharmaceutical Formulations Comprising This Active Ingredient
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Dec 27, 2019
Patent Number:
EP2711024
Title:
Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same
Applicant:
UNITED THERAPEUTICS CORPORATION
Opposition Date:
Dec 5, 2019
Patent Number:
EP2348832
Title:
Preservative System For Emulsion-Based Therapeutic Topical Formulations
Applicant:
ARBOR PHARMACEUTICALS, LLC
Opposition Date:
Oct 16, 2019
Patent Number:
EP3143995
Title:
A Rapamycin Derivative For Treating Lung Cancer
Applicant:
NOVARTIS AG
Opposition Date:
Sep 5, 2019
Patent Number:
EP3078667
Title:
Formulation Of Boronic Acid Compounds
Applicant:
THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Opposition Date:
Aug 21, 2019
Patent Number:
EP3042659
Title:
Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione
Applicant:
CELGENE CORPORATION
Opposition Date:
Aug 7, 2019
Patent Number:
EP3045175
Title:
Polymorphic Forms Of 3-(4-Amino-1-Oxo-1,3 Dihydroisoindol-2-Yl)-Piperidine-2,6-Dione
Applicant:
CELGENE CORPORATION
Opposition Date:
Aug 7, 2019
Patent Number:
EP2694049
Title:
Tapentadol For Preventing Chronification Of Pain
Applicant:
GRÜNENTHAL GMBH
Opposition Date:
Jul 31, 2019

Competitors of Generics [uk] Ltd

CELGENE CORPORATION

NOVARTIS AG

NOVARTIS INTERNATIONAL PHARMACEUTICAL AG

Want to track Generics [uk] Ltd?

Feel free to send us a message here and we will get back to you